The results revealed that high PHF19 expression predicted worse OS in BC (bladder carcinoma), KIRC, KIRP, LIHC, LUAD, LUSC, and UCEC, nevertheless, patients with higher PHF19 expression showed remarkably improved OS in HNSC, SARC, THCA, and THYM (all log-rank P values < 0.05) (Figure 2B). The gene discussed is PHF19; the disease is breast cancer.